Rabourn Amy Zaremba

CIK: 0001832343

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)3 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRD

Opus Genetics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

IRD
Opus Genetics, Inc.
Apr 23, 2026
Sale(S)
Direct
1.6K shares at avg. $5.20$9K
IRD
Opus Genetics, Inc.
Mar 16, 2026
Sale(S)
Direct
2.8K shares at avg. $5.25$15K
IRD
Opus Genetics, Inc.
Jan 22, 2026
Award(A)
Direct
86.5K shares-
IRD
Opus Genetics, Inc.
Jan 18, 2026
Tax Payment(F)
Direct
3.4K shares at avg. $2.10$7K
IRD
Opus Genetics, Inc.
Jan 10, 2026
Tax Payment(F)
Direct
4K shares at avg. $1.93$8K
IRD
Opus Genetics, Inc.
Mar 13, 2025
Award(A)
Direct
39.5K shares-
IRD
Opus Genetics, Inc.
Feb 4, 2025
Tax Payment(F)
Direct
8.2K shares at avg. $1.14$9K

		Type	Shares	Price		Ownership
Apr 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	1,641	$5.20	$8,540	Direct
Mar 16, 2026	IRD Opus Genetics, Inc.	Sale(S)	2,816	$5.25	$14,770	Direct
Jan 22, 2026	IRD Opus Genetics, Inc.	Award(A)	86,500	-	$0	Direct
Jan 18, 2026	IRD Opus Genetics, Inc.	Tax Payment(F)	3,390	$2.10	$7,119	Direct
Jan 10, 2026	IRD Opus Genetics, Inc.	Tax Payment(F)	3,950	$1.93	$7,624	Direct
Mar 13, 2025	IRD Opus Genetics, Inc.	Award(A)	39,500	-	-	Direct
Feb 4, 2025	IRD Opus Genetics, Inc.	Tax Payment(F)	8,190	$1.14	$9,337	Direct

1-7 of 7 transactions

About Zaremba Rabourn Amy

Zaremba Rabourn Amy (SEC CIK 0001832343) files insider reports with the SEC as Head of Fin. Quality Assurance of Opus Genetics, Inc. (IRD).

Signal8 holds 7 ownership filings by Zaremba Rabourn Amy, all Form 4s, filed between Feb 6, 2025 and Apr 27, 2026. Those filings report 7 transactions, from Feb 4, 2025 to Apr 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Zaremba Rabourn Amy's filings is in DURHAM, NC.

Recent filings by Zaremba Rabourn Amy

Apr 23, 2026: Open-market sale of IRD shares (Form 4, code S).
Mar 16, 2026: Open-market sale of IRD shares (Form 4, code S).
Jan 22, 2026: Grant or award of IRD shares (Form 4, code A).
Jan 18, 2026: Tax withholding of IRD shares (Form 4, code F).
Jan 10, 2026: Tax withholding of IRD shares (Form 4, code F).

Other insiders filing for Opus Genetics, Inc. (IRD)

SCHACHLE JOSEPH K, Chief Operating Officer
YERXA BENJAMIN R, President
Gagnon Robert E., Chief Financial Officer
Magrath George, Chief Executive Officer
Foundation Fighting Blindness Retinal Degeneration Fund, Director
Gallagher Cam, Director

How to read Form 4 transaction codes